Manages clinical trials for pharmaceutical and medical device companies.
Jun 2026Revenue $2.68B/yrExpenses $2.69B/yr
Fell below break-even Feb 2024
Figures by year
When will Fortrea Holdings be profitable again?
Its expenses passed its revenue in Feb 2024. In the 12 months to Jun 2026, revenue was $2.68B and expenses $2.69B.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $2.72B | $3.60B | −$873M |
| Dec 2024 | $2.70B | $2.86B | −$162M |
| Dec 2023 | $2.84B | $2.81B | $32.0M |
| Dec 2022 | $2.84B | $2.65B | $187M |
| Dec 2021 | $3.06B | $2.94B | $114M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.